- cafead Dec 26, 2019 at 01:22: PM
via Eliquis, the blockbuster blood thinner that has been a leading fixture in Bristol-Myers’ top line for years, now has FDA approved copycats.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for...
- Thread starter cafead
- Start date
<
Similar threads